A modified growth-hormone fragment studied for lipolytic and fat-metabolism pathways.

| Compound | AOD-9604 |
| Also known as | AOD9604 |
| CAS Number | 221231-10-3 |
| Molecular Weight | 1,815.1 g/mol |
| Sequence / Form | Modified hGH(176-191) fragment |
| Classification | Metabolic research compound |
| Appearance | Lyophilized powder |
| Purity | ≥99% (HPLC · MS-verified) |
| Storage | 2–8°C; -20°C for long-term |
| Intended Use | Research Use Only |
AOD-9604 is a synthetic modified fragment of human growth hormone corresponding to the C-terminal residues 176-191 with a tyrosine modification. Research focuses on its lipolytic activity and effects on fat metabolism.
A distinguishing research property is that it is studied for metabolic effects without IGF-1 receptor activation or the growth-promoting effects of full-length hGH.
Every Ethos Bio lot of AOD-9604 is analyzed by reverse-phase HPLC and independently confirmed by mass spectrometry through our third-party testing partner, Janoshik Analytical. A signed Certificate of Analysis documenting identity and ≥99% purity is provided for every lot.
Independent third-party HPLC & mass-spec verification. The COA shipped with your order reflects your specific lot.
What is AOD-9604?
AOD-9604 is a modified hGH(176-191) fragment studied for lipolytic and fat-metabolism pathways in research models, without IGF-1 activation. It is a research-use-only compound.
Does AOD-9604 affect IGF-1?
In research models AOD-9604 is studied for fat-metabolism effects without IGF-1 receptor activation, distinguishing it from full-length growth hormone.
What is AOD-9604\u2019s molecular weight?
AOD-9604 has an approximate molecular weight of 1,815.1 g/mol and CAS number 221231-10-3.